Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ronnevik PK:

Search results

Items: 1 to 20 of 30

1.

Effects of extended-release niacin with laropiprant in high-risk patients.

HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J.

N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955.

2.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
3.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines.

Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105. No abstract available. Erratum in: Eur J Heart Fail. 2013 Mar;15(3):361-2.

4.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines.

Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19. No abstract available. Erratum in: Eur Heart J. 2013 Jan;34(2):158.

PMID:
22611136
5.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif JC, Ponikowski P, Kahan T; ASSOCIATE Study Investigators.

Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.

6.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
7.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

8.

[Treatment of congestive heart failure].

Aarønaes M, Atar D, Bonarjee V, Gundersen T, Løchen ML, Mo R, Myhre ES, Omland T, Rønnevik PK, Vegsundvåg J, Westheim A.

Tidsskr Nor Laegeforen. 2007 Jan 18;127(2):174-7. Review. Norwegian.

9.

[Congestive heart failure--etiology and diagnostic procedures].

Aarønaes M, Atar D, Bonarjee V, Gundersen T, Løchen ML, Mo R, Myhre ES, Omland T, Rønnevik PK, Vegsundvåg J, Westheim A.

Tidsskr Nor Laegeforen. 2007 Jan 18;127(2):171-3. Review. Norwegian.

10.

Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine.

Lund-Johansen P, Stranden E, Helberg S, Wessel-Aas T, Risberg K, Rønnevik PK, Istad H, Madsbu S.

J Hypertens. 2003 May;21(5):1003-10.

PMID:
12714876
11.

Prognostic value of exercise testing.

Rønnevik PK.

Eur Heart J. 2001 Sep;22(17):1626. No abstract available.

PMID:
11492993
12.

[Chronic heart failure--suggestion to a management program].

Westheim A, Dickstein K, Gundersen T, Hole T, Kjekshus J, Myhre ES, Rønnevik PK, Samstad S, Smith P.

Tidsskr Nor Laegeforen. 1999 Sep 30;119(23):3427-31. Review. Norwegian.

PMID:
10553340
13.

[Calcium channel blockers in heart failure].

Hole T, Dickstein K, Gundersen T, Kjekshus J, Myhre ES, Rønnevik PK, Westheim AS.

Tidsskr Nor Laegeforen. 1997 Jun 20;117(16):2329-32. Review. Norwegian.

PMID:
9265278
14.
15.

Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.

Rønnevik PK, Nordrehaug JE, von der Lippe G.

Eur J Clin Pharmacol. 1995;48(2):127-31.

PMID:
7589026
16.

[Chronic heart failure. A management program. Proposal for diagnosis and treatment].

Westheim A, Dickstein K, Gundersen T, Hole T, Myhre ES, Rønnevik PK, Smith P, Kjekshus J.

Tidsskr Nor Laegeforen. 1994 May 10;114(12):1424-7. Norwegian.

PMID:
8079230
17.

Importance of the exercise programme for the assessment of functional capacity after myocardial infarction.

Rønnevik PK, Nordrehaug JE, von der Lippe G.

Scand J Clin Lab Invest. 1993 May;53(3):231-8.

PMID:
8316752
19.

Increased occurrence of exercise-induced silent ischemia after treatment with aspirin in patients admitted for suspected acute myocardial infarction.

Rønnevik PK, Følling M, Pedersen D, Rodt SA, von der Lippe G.

Int J Cardiol. 1991 Dec;33(3):413-7.

PMID:
1761336
20.

Effect of metoprolol on early exercise-induced ST-segment changes and ventricular arrhythmias in patients with suspected acute myocardial infarction.

Rønnevik PK, Gundersen T, Abrahamsen AM, Knutsen H, Woie L.

Int J Cardiol. 1989 Jan;22(1):51-7.

PMID:
2647644

Supplemental Content

Loading ...
Support Center